Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab

Overview of attention for article published in International Journal of Retina and Vitreous , April 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 1,474 followers.

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab https://t.co/PDXshXChul

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.